Completion of Transaction

RNS Number : 1433O

Circassia Group Plc

28 May 2020

 

28 May 2020

Circassia Group plc

Completion of Transaction

Circassia Group plc ("Circassia" or "the Company") announces that the proposed transfer of the Tudorza and Duaklir assets to AstraZeneca first announced on 9 April 2020 has now completed.

Ian Johnson, Executive Chairman of Circassia, said:  "The completion of this transaction transforms Circassia into a debt-free business.  Niox® is a highly differentiated respiratory diagnostic platform that will be able to deliver long-term growth and enhanced shareholder returns."

-Ends-

For further information, please contact:

Circassia Group plc Ian Johnson, Executive Chairman	c/o Peel Hunt
Michael Roller, CFO
Peel Hunt (Nominated Adviser and Joint Broker)	Tel: [phone]
James Steel / Oliver Jackson
finnCap (Joint Broker)	Tel: [phone]
Geoff Nash / Alice Lane
Numis Securities (Joint Broker)	Tel: [phone]
James Black / Duncan Monteith

 

END

 

 

DISFFFEIEVIDFII